
Adhera Therapeutics, Inc. – OTC:ATRX
Adhera Therapeutics stock price today
Adhera Therapeutics stock price monthly change
Adhera Therapeutics stock price quarterly change
Adhera Therapeutics stock price yearly change
Adhera Therapeutics key metrics
Market Cap | 2.27M |
Enterprise value | 2.48M |
P/E | -0.47 |
EV/Sales | N/A |
EV/EBITDA | 4.06 |
Price/Sales | N/A |
Price/Book | -0.05 |
PEG ratio | N/A |
EPS | -0.51 |
Revenue | N/A |
EBITDA | -1.73M |
Income | -2.52M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAdhera Therapeutics stock price history
Adhera Therapeutics stock forecast
Adhera Therapeutics financial statements
Dec 2022 | 0 | 1.62M | |
---|---|---|---|
Mar 2023 | 0 | -886K | |
Jun 2023 | 0 | 271K | |
Sep 2023 | 0 | -3.53M |
Payout ratio | 0% |
---|
2018 | 35.06% |
---|---|
2019 | 231.38% |
2020 | 341.18% |
2021 | 225.65% |
2022 |
Dec 2022 | 79000 | 22.26M | 28183.54% |
---|---|---|---|
Mar 2023 | 104000 | 23.19M | 22304.81% |
Jun 2023 | 82000 | 22.86M | 27889.02% |
Sep 2023 | 44074 | 26.35M | 59807.4% |
Dec 2022 | -153K | 0 | 52K |
---|---|---|---|
Mar 2023 | -310K | 0 | 347K |
Jun 2023 | -316K | 0 | 305K |
Sep 2023 | -29.15K | 0 | 3.78K |
Adhera Therapeutics alternative data
Aug 2023 | 2 |
---|---|
Sep 2023 | 2 |
Oct 2023 | 2 |
Nov 2023 | 2 |
Dec 2023 | 2 |
Jan 2024 | 2 |
Feb 2024 | 2 |
Mar 2024 | 2 |
Apr 2024 | 2 |
May 2024 | 2 |
Jun 2024 | 2 |
Jul 2024 | 2 |
Adhera Therapeutics other data
Period | Buy | Sel |
---|---|---|
Apr 2018 | 2564627 | 0 |
Jul 2018 | 300040 | 0 |
Insider | Compensation |
---|---|
Mr. Andrew Albert Kucharchuk (1981) Chief Executive Officer & Chairman | $124,140 |
-
What's the price of Adhera Therapeutics stock today?
One share of Adhera Therapeutics stock can currently be purchased for approximately $0.
-
When is Adhera Therapeutics's next earnings date?
Unfortunately, Adhera Therapeutics's (ATRX) next earnings date is currently unknown.
-
Does Adhera Therapeutics pay dividends?
No, Adhera Therapeutics does not pay dividends.
-
How much money does Adhera Therapeutics make?
Adhera Therapeutics has a market capitalization of 2.27M.
-
What is Adhera Therapeutics's stock symbol?
Adhera Therapeutics, Inc. is traded on the OTC under the ticker symbol "ATRX".
-
What is Adhera Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Adhera Therapeutics?
Shares of Adhera Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Adhera Therapeutics's key executives?
Adhera Therapeutics's management team includes the following people:
- Mr. Andrew Albert Kucharchuk Chief Executive Officer & Chairman(age: 44, pay: $124,140)
-
How many employees does Adhera Therapeutics have?
As Jul 2024, Adhera Therapeutics employs 2 workers.
-
When Adhera Therapeutics went public?
Adhera Therapeutics, Inc. is publicly traded company for more then 31 years since IPO on 15 Apr 1994.
-
What is Adhera Therapeutics's official website?
The official website for Adhera Therapeutics is adherathera.com.
-
Where are Adhera Therapeutics's headquarters?
Adhera Therapeutics is headquartered at PO Box 2161, Wake Forest, NC.
-
How can i contact Adhera Therapeutics?
Adhera Therapeutics's mailing address is PO Box 2161, Wake Forest, NC and company can be reached via phone at +91 95183748.
Adhera Therapeutics company profile:

Adhera Therapeutics, Inc.
adherathera.comOTC
2
Biotechnology
Healthcare
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Wake Forest, NC 70820
CIK: 0000737207
ISIN: US00687E1091
CUSIP: 00687E109